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ABSTRACT 
Supramolecular complexes of a family of positively charged conjugated polymers (CPs) and 
green fluorescent protein (GFP) create a fluorescence resonance energy transfer (FRET)-based 
ratiometric biosensor array. Selective multivalent interactions of the CPs with mammalian cell 
surfaces caused differential change in FRET signals, providing a fingerprint signature for each 
cell type. The resulting fluorescence signatures allowed the identification of sixteen different cell 
types and discrimination between healthy, cancerous, and metastatic cells, with the same genetic 
background. While the CP-GFP sensor array completely differentiated between the cell types, 
only partial classification was achieved for the CPs alone, validating the effectiveness of the 
ratiometric sensor. The utility of the biosensor was further demonstrated in the detection of 
blinded unknown samples, where 121 of 128 samples were correctly identified. Notably, this 
selectivity-based sensor stratified diverse cell types in minutes, using only 2000 cells, without 
requiring specific biomarkers or cell labelling.  
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INTRODUCTION 
Combating cancer demands fast and efficient detection and monitoring of the disease progress.  
A generalized approach for identifying different cancer types and states is achieved by profiling 
their genomic,
1
 transcriptomic,
2
 proteomic,
3
 and metabolomic
4
 signatures that provide a reliable 
correlation between the healthy and disease state. In addition to identifying cancers and their 
subtypes, profiling molecular signatures of a cell type allows prediction of potential neoplastic 
transformation of normal cells or benign tumors,
5
 enabling the personalized screening of disease 
states. Notably, these signature-based approaches identify wide varieties of cancer types, 
overcoming limitations of traditional specific biomarker-based methods such as the lack of 
appropriate markers for every cancer type and false positive diagnosis.
6
 While specific 
intracellular signatures are promising for cancer cell detection, phenotypic signatures of cell 
surfaces
7
 enable construction of a rapid, simple, and generic diagnostic tool for identifying cell 
types and their states. The surface signature-based sensing method applies to any cell type and 
makes additional processing steps to extract the genetic materials, proteins, glycoproteins, or 
other biomarkers unnecessary.  
Differential sensor arrays featuring cross-reactive receptors provide an ideal platform for 
surface phenotype-based mammalian cell detection. The differential sensing methods (also called 
“chemical nose/tongue”) create a unique response signature for each analyte through differential 
receptor-analyte binding interactions, allowing them to be ‘trained’ to identify diverse analytes 
both individually and in mixtures.
8
 The signature-based strategy is a powerful technique for the 
detection of bioanalytes including amino acids,
9
 carbohydrates,
10
 proteins,
11
 and bacteria.
12
 
Likewise, biosensor arrays with non-ratiometric sensor responses have been developed for 
profiling cell-surface signatures, enabling identification of a few different mammalian cell 
types.
13
 We envisage that a generalized biosensor array with ratiometric output, high sensitivity, 
and minimum number of sensor elements would provide robust and universal cell diagnostics.    
Thanks to their easily tailorable multivalent functionalities and excellent light harvesting 
properties, water-soluble conjugated polymers offer an excellent scaffold for cell surface-based 
biosensor design.
14
 Unlike small-molecule fluorophores, the delocalized electronic structure of 
CP backbones with large numbers of light absorbing units allows efficient intra- and inter-chain 
energy transfer that amplifies the signal of acceptors.
15
 Moreover, their optical properties (e.g. 
absorption and emission) are sensitive to conformational or environmental changes, enabling 
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sensitive detection of the subtle differences between analytes.
15,16
 A key feature of CPs 
containing pendant charged functional groups is their ability to form supramolecular complexes 
with charge complementary macromolecules, producing fluorescence quenching or fluorescence 
resonance energy transfer (FRET). Using the FRET modulation mechanism, CPs have provided 
simple, sensitive, and ratiometric platforms for detecting bioanalytes
17
 including nucleic acids,
18
 
proteins,
19
 glycans,
20
 and bacteria.
21
 While functionalized CPs have demonstrated cell 
recognition abilities,
22,23
 utilizing them in FRET-based cell sensing platforms could be 
instrumental in increasing the sensitivity and minimizing the common interferences in the 
conventional cell sensing methods, caused by the sample heterogeneity (cell morphology, and 
size) and phenotypic diversity.  
Herein, we introduce a new biosensor using supramolecular conjugates of CP-green 
fluorescent protein (GFP) that provides a universal platform for the rapid (within minutes) and 
sensitive (only ~2000 cells) identification of diverse mammalian cell types utilizing their 
‘fingerprint’ surface phenotypes. The key feature of this biosensor is the cell binding-mediated 
generation of a ratiometric response that cancels out experimental factors such as the sample 
variability, total sensor concentration, and instrument variation; we completely differentiate 
sixteen different cell types with healthy/tumorigenic/metastatic states. Moreover, emission 
ratioing to estimate the FRET response increases the reproducibility and reliability of detection, a 
major requirement for non-specific array-based sensors. Notably, this ratiometric sensor array 
not only works significantly better than the quenching-based non-ratiometric CP array, its ability 
to profile diverse cell types with challenging features such as isogenic origin, difference in 
metastatic potency, and subtle variation in glycosylation patterns based on cell-surface features 
makes it a generalized cell detection toolkit.   
The underlying principle of mammalian cell sensing by our CP-based ratiometric 
biosensor is illustrated schematically in Figure 1. Herein, assembly of cationic CPs with charge 
complementary GFP produces supramolecular assemblies that exhibit FRET processes, where 
the polymers and GFP act as the donor and acceptor, respectively. Multivalent binding of the 
polymers with cell surfaces modulates the FRET signal of the CP-GFP complexes, and provides 
a direct transduction of the binding events. The differential interactions between the polymers 
and cell surface functionalities (such as proteins, lipids, and glycans) generate changes in FRET 
responses that are characteristic of a cell type. Subsequently, chemometric analysis on such 
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responses creates reference patterns for different cells (“training set”) that identify unknown 
samples (“test set”). 
 
Figure 1. Schematic illustration of FRET-based cell sensing using CP-GFP complexes. (a) The 
polymers and GFP form supramolecular complexes through electrostatic interactions, giving rise to FRET 
responses that are modulated when the complexes interact with cell surface. (b) Chemical structures and 
characteristics of the cationic CPs used in the study. Mn: number average molecular weight; Mw: weight 
average molecular weight; PDI: polydispersity index. 
 
RESULTS AND DISCUSSION 
We constructed four supramolecular FRET pairs using GFP and water-soluble functionalized 
CPs. Unlike small molecule fluorophores, the chromophore in GFP is protected inside a robust 
beta barrel protein structure,
24
 providing excellent fluorescence properties including high 
photostability. Another advantage of using GFP as a fluorophore is its strong electrostatic 
interactions with cationic molecules, owing to net negative charges under the experimental 
buffer conditions (pH 7.4) (Table S2). On the other hand, the ease of functionalization of the CP 
backbone made it possible to synthesize poly(p-phenyleneethynylene)s P1 – P4 (Figure 1b) with 
tailored cationic charge densities and degrees of polymerization
25
 that are expected to display 
differential binding with GFP. These CPs were selected for the cell sensing assay based on 
previous studies that demonstrated their effectiveness in profiling cells through differential 
binding.
23
 We estimated the overlap integral (Table S3) between the emission spectra of the CPs 
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and the absorption spectrum of GFP (Figure S2) that satisfied the requirement
26
 for FRET. 
Therefore, upon excitation at the P1 – P4 absorbance band of 430 nm, the CP-GFP 
supramolecular complexes exhibit efficient FRET from the CPs to GFP (Figure 2a and S3), with 
decreased fluorescence emission at 466 nm and sensitized emission at 510 nm. The results for 
the spectral overlap integral (J), Förster distance (R0), maximum energy transfer efficiency 
(Emax), and donor-acceptor separation distance (R) are summarized in Table S3. The short 
separation distance among all the FRET pairs indicates good supramolecular affinity between the 
CPs and GFP. 
 
Figure 2. FRET between CPs and GFP. (a) Emission spectra as a function of GFP concentration for the 
P3-GFP pair. [P3] = 8 nM; 5 mM sodium phosphate buffer. (b) Quenching of P3 fluorescence (blue 
circles) and the corresponding FRET efficiency (green squares) as a function of the increasing GFP 
concentration. Each value is the average of three independent measurements and the error bars are the 
± standard deviations (SD). Solid lines represent the best-fitted curves, where the blue line is obtained 
from fitting the binding equation based on the model of single set of identical binding sites and the green 
line is obtained through fitting the Förster equation (See SI).  
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To develop the sensing arrays, we determined the ratio of CP and GFP that corresponds 
to maximum FRET efficiency as estimated from the polymer fluorescence loss
27
 (Figure 2b and 
S4). Fitting of the titration data (Figure 2b and S5) revealed differential affinities (Table S4) 
between the four CPs and GFP, indicating the possibility of selectivity-based sensing. 
Fluorescence titration with P5 (Figure S1 and S3), the negative control, demonstrates that the 
primary interaction between polymer and GFP is electrostatic. Once the optimal CP-GFP ratio 
was determined, we prepared the sensors by mixing appropriate stoichiometry of polymer and 
GFP, and tested the ability of this sensor array to detect mammalian cells using ratiometric 
emissions. Titration of the CP-GFP complexes with different concentrations of cell suspensions 
showed a stable and differentiable change in FRET response with as few as 2000 cells. Using the 
initial linear slope, a calibration curve of cell concentration-dependent FRET responses (such as 
Figure S6) would allow quantitative detection of cells within the limited dynamic range. 
Table 1: Features of the isogenic murine and human cell lines with their cell status. 
Cell line Tissue origin Cell status 
CDβGeo Breast Normal immortalized 
pTD Breast Tumorigenic 
V14 Breast Metastatic 
NCI-H1299 
(parental) 
Lung Metastatic 
Subline-1 Adrenal Highly metastatic 
Subline-2 Bone Highly metastatic 
Subline-5 Ovary Highly metastatic 
  
As a robust starting point for mammalian cell sensing, we sought to differentiate between 
genetically identical (isogenic) cells with healthy and cancerous states. In sensor development, 
the differentiation of isogenic cells presents a particularly challenging task for signature-based 
sensors owing to the lack of cell-surface phenotypic differences that arise from genetic 
diversities. Therefore, the isogenic cells provide ideal targets for sensor validation. We tested 
three murine cell lines obtained from the mammary fat pads of BALB/c mice as the reliable 
isogenic targets: CDβGeo, pTD, and V14 that are respectively normal, cancerous, and metastatic 
cell types
28
 (Table 1). Incubation of the cells with the CP-GFP complexes caused a decrease in 
sensitized GFP fluorescence and an increase in polymer fluorescence (Figure 3a), indicating 
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dissociation of the complexes by the competitive binding of the cationic polymers with cells 
leading to FRET inhibition. Additionally, polymer fluorescence is quenched due to aggregation 
of polymers on cell surfaces
23
 (Figure S7) that depends on the polymer as well as interacting cell 
types. The relative changes in FRET responses were quantified by FR, as defined in equation (1): 
 
where, FRET and FRET0 are the ratio of emission intensities at 510 nm to 466 nm with and 
without cells, respectively. We observed distinct differences in FRET response patterns from the 
four independent polymer-GFP dyads for each cell line (Figure 3b), indicating differential 
interaction of the polymers and cell surfaces. Hierarchical clustering analysis (HCA) of the 
FRET responses produced three distinct branches (Figure 3c), each corresponding to a cell type. 
The distinct and characteristic responses for each cell type demonstrate the sensitivity and 
selectivity of the CP-GFP sensor to cell surface functionalities, indicating effective FRET 
response-based fingerprinting of cell types/states.  
Given the multidimensional nature of the sensor output, it is essential to reduce the 
dimensionality of the data sets for identifying the patterns and trends among the analytes, and 
establishing a quantitative classifier to identify unknown samples. For this purpose, we employed 
linear discriminant analysis (LDA),
29
 a supervised statistical method that maximizes the ratio of 
between- vs within-class variation. Separation between data points on an LDA plot demonstrates 
the differences between them. LDA on the above FRET data set (3 isogenic cell lines × 8 
replicates × 4 CP-GFP complexes) resulted in two canonical factors explaining the total variance. 
A score plot constructed using the canonical factors produced three non-overlapping clusters 
corresponding to the three cell lines (Figure 3d), indicating excellent discriminatory capacity of 
the method. To assess the reliability of the LDA method in correctly classifying sample 
observations, leave-one-out cross-validation analysis was performed on all the response data. 
The jackknifed analysis (a leave-one-out exercise on LDA) on the data set revealed 100% cross-
validation accuracy (Figure S8a), demonstrating the LDA method to be a robust statistical tool 
for this system. Furthermore, the Wilks lambda parameter for the training set was derived to be 
0.009 (F = 44.8, P = 0.0000), the small value of which supports LDA to be a strong model for 
the present analyses. Overall, the differential interaction of the sensor combined with the robust 
statistical analysis suggests the feasibility of FRET response-based identification of diverse types 
of mammalian cells in a rapid, sensitive, and label-free manner. 
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Figure 3. Detection of isogenic murine cells at different states. (a) Initial fluorescence spectrum (red) 
of the P2-GFP complex and final spectrum upon incubation with CDβGeo cells. (b) Change in FRET 
responses (FR) from the CP-GFP complexes upon interacting with the isogenic murine breast cell types, 
where each value is the average of eight independent measurements and the error bars are the ± SD. (c) 
Clustering analysis of the FRET responses. Hierarchical clustering was performed on the raw data set (3 
cell lines × 8 replicates × 4 CP-GFP complexes) using a correlation metric and average linkage. (d) LDA 
score plot of the FRET responses. The analysis resulted in canonical scores with two discriminants 
explaining 93.4%, and 6.6% of total variance and was plotted with 95% confidence ellipses around the 
centroid of each group.  
We tested the generality of the CP-GFP sensor using another set of isogenic human cell 
lines: NCI-H1299, a non-small cell lung cancer (NSCLC) line, and three derived anatomical site-
specific metastatic cell lines (subines) with different metastatic propensity. Site-specific 
metastasis is an important factor in determining cancer progression and therapeutic treatments. 
We established three metastatic sublines (Table 1) using cells isolated from metastatic lesions in 
the adrenal gland, bone, and ovary that developed following arterial (intra-cardiac) inoculation of 
human NCI-H1299 cells in mice.
30,31
 Multiple passages in tissue culture and cell sorting 
provided pure populations of the metastatic sublines. These three sublines exhibited significantly 
enhanced metastatic capacity as well as variable degrees of tissue tropism. We evaluated the in 
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vitro cultured parental NCI-H1299 cell line and the sublines using the CP-GFP sensor array. The 
FRET response patterns from these cells (Figure 4a) were found to be distinct, and characteristic 
of each cell type. Analysis of the ratiometric FRET responses by LDA resulted in three canonical 
discriminants (77.8%, 12.2%, and 2.0%), with the two most significant discriminants plotted in 
Figure 4b. Significantly, the different cell types clustered into four non-overlapping groups, with 
100% cross-validation accuracy (Figure S8b). These results validate the ability of the sensor to 
discriminate between the parental cancerous line and the metastasis-derived sublines, as well as 
between site-specific metastasis (adrenal, bone, and ovary) based on the cell-surface phenotypic 
variations. 
 
Figure 4. Detection of murine isogenic site-specific metastatic cells. (a) Change in FRET responses 
(FR) from the polymer-GFP complexes upon interacting with the four murine metastatic cell types, where 
each value is the average of six independent measurements and the error bars are the ± SD. (b) LDA score 
plot of the fluorescence responses. The analysis resulted in canonical scores with three discriminants 
explaining 77.8%, 12.2%, and 2.0% of total variance and was plotted with 95% confidence ellipses 
around the centroid of each group.  
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The versatility of the CP-GFP array sensor was further demonstrated through the 
detection of (non-isogenic) human cell types with different cell states. One normal breast cell 
line MCF10A and four cancer cell lines were used in this study (Table S5). The cancer cell lines 
comprised: HeLa (cervical adenocarcinoma) and HepG2 (hepatocellular carcinoma), derived 
from primary tissue sites; and MCF7 (breast adenocarcinoma) and NT2/D1 (embryonal 
carcinoma), derived from metastatic sites and containing metastatic features. These healthy, 
cancerous, and metastatic cell types were clustered into five respective groups through LDA on 
the FRET responses (Figure S9), with 100% cross-validated accuracy (Figure S8c).  In all, the 
simple biosensor is a generic mammalian cell sensor, highlighting that the molecular interaction 
of the CP-GFP complexes with the cell surface provides characteristic signatures for each 
mammalian cell type.  
Table 2: Features of the Chinese hamster ovary cell lines used in the current studies. 
Cell line Features of the cell lines Cell status 
CHO-K1 Wild-type epithelial-like; derived as a subclone from the 
parental CHO cells 
Tumorigenic 
pgsA-745 CHO-K1-dervied cells deficient in proteoglycans (~8% of 
the parental cells) 
Non-tumorigenic 
pgsB-618 CHO- K1-dervied cells deficient in proteoglycans (~15% 
of the parental cells) 
Tumorigenic 
pgsD-677 CHO- K1-dervied cells deficient in heparin sulfate; 3-4 
fold higher chondroitin sulfate than CHO-K1 cells 
Non-tumorigenic 
 
After validating the sensing platform, we focused on differentially glycosylated cell lines 
to investigate the effect of glycome structure on the ratiometric FRET response patterns, as the 
mammalian cell surfaces are covered with dense layers of glycans that largely regulate the 
extracellular biochemical interactions. Given the electrostatic basis of the sensor, we tested 
isogenic glycosaminoglycan (GAG)-modified cell lines that provide a robust testbed to validate 
the interaction of the polymers with cell-specific glycans as a sensing mechanism.
32
 We studied a 
wild-type and GAG-mutant Chinese hamster ovary (CHO) cell lines (Table 2) that are benign or 
tumorigenic depending on the proteoglycan composition of the cell surface.
33
 For example, 
mutant CHO cell types defective in the synthesis of heparan sulfate (HS) proteoglycans do not 
form tumors, whereas mutants with altered chondroitin sulfate proteoglycans are tumorigenic.
33a
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Figure 5. Sensing of isogenic glycan-engineered cell types. (a) Clustering analysis of the FRET 
responses obtained from the four CHO cell types. Hierarchical clustering was performed on the FR values 
(4 CHO cell lines × 8 replicates × 4 CP-GFP complexes) using a correlation metric and average linkage. 
The numbers at the bottom correspond to the replicates. (b) LDA score plot of the FRET responses. The 
analysis resulted in canonical scores with three discriminants explaining 85.5%, 13.0%, and 1.5% of total 
variance and is plotted with 95% confidence ellipses around the centroid of each group.  
Upon addition of the CHO cell variants to the CP-GFP sensor array, differential FRET 
responses were observed for the wild-type and glyco-engineered cell lines (Figure S10). 
Unsupervised HCA was performed on the FRET responses to visualize the relation between the 
wild-type and the glycomutated cells. It is readily observed that the glyco-engineered cells with 
diminished GAGs are classified into different branches in the dendrogram than the wild-type 
cells (Figure 5a), indicating the major contribution of proteoglycans in generating the sensor 
responses. Together with other reports on cationic polyelectrolytes,
32,34
 this study provides an 
insight into the central role of proteoglycans in controlling the polymer-cell interactions. 
Furthermore, we employed LDA on the FRET responses that classified the 32 sample 
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observations (4 cell lines × 8 replicates) into four quantifiably distinct clusters (Figure 5b) with 
100% cross-validation accuracy (Figures S8d), demonstrating their effective classification. 
Therefore, subtle variation in GAG composition on the cell surfaces can be reliably distinguished 
by the FRET sensor system, providing a useful tool for glycan biomarker-based cancer detection.  
After demonstrating the selective polymer-cell surface interaction for differentiating 
between diverse cell types, we assessed the importance of each CP in generating the differential 
FRET responses for each cell type. Analysis of the FRET responses from all the sixteen cell lines 
revealed that each of the four CPs significantly contributes to the overall sensing capabilities (see 
the discussion on contribution of each CP in the Supporting Information). In addition, correlation 
(Pearson’s) of the canonical scores with FRET responses from each CP (Figure S11) validated 
the involvement of the four polymer-GFP dyads in the effective classification. Moreover, we 
evaluated the usefulness of the ratiometric FRET signals in cell detection compared to the 
fluorescence quenching of the CPs on cell surfaces by incubating the polymers (P1 – P4) alone 
with the glyco-mutant cells. The resulting fluorescence quenching patterns were subjected to 
LDA that produced overlapped clusters with 63% cross-validated accuracy (Figure S13). 
Likewise, the metastatic sublines could be differentiated only with 72% accuracy. Therefore, the 
ratiometric CP-GFP sensor has a synergistic advantage over the polymers themselves. 
A key requirement for diagnostic applications of the signature-based detection tools is the 
ability to identify unknown samples. Building upon the training sets that we established by the 
LDA clustering above, we performed tests on a randomised set of 128 unknown samples 
prepared from these cells. The unknowns were blinded during the measurements and analysis. 
An algorithm was used in LDA to compute the Mahalanobis squared distance between the test 
samples and each cell type within the corresponding training set. The test samples were 
classified to the cell type for which the distance was minimal (Figure 6a). Using this approach, 
121 of the 128 unknowns were correctly identified with a 94.5% accuracy (Figure 6b and Table 
S10 – S13), validating the reliability of the sensor in detecting cells and the robustness of LDA 
clustering methodology.  
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Figure 6. Identification of unknown samples. (a) Schematic of unknown detection using LDA, where d 
is the squared Mahalanobis distance. (b) Result of unknown detection using a LDA algorithm (see SI 
methods section S13). 
The above results demonstrate that fluorescence signatures of polymer-cell interactions 
enable efficient differentiation and identification of diverse healthy and cancerous cell types, 
making the sensor useful in cancer diagnostics. However, applications of the sensing approach in 
clinical settings including real-time identification of an unknown cell type (outside the training 
set) would rely on its ability to predict the cell status from the known training set. Analysis of the 
above experimental results together with previous reports
30,35
 on selectivity-based cell sensors 
indicates a clear demarcation between normal and diseased cells/tissues, suggesting the 
feasibility of discernible patterns of healthy and malignant cells. In addition, construction of a 
global database of fluorescence fingerprints of a large number of healthy and cancer cells would 
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ensure accurate and rapid identification of malignancies at different stages. Development of 
diverse polymer structures, enhancement of sensor-analyte selectivity, and evaluation of 
appropriate statistical methods for large data analysis would likely constitute the next steps to 
realize the broader applicability of the fingerprinting approach in clinical biodiagnostics. 
 
CONCLUSIONS 
In summary, we have developed an efficient and highly sensitive ratiometric sensor array using 
CP-GFP supramolecular complexes and demonstrated its utility in identifying mammalian cells 
in minutes. The biosensor benefits from the high fluorescence sensitivity as well as signal 
amplification effects of the CPs, and the strong affinity of the macromolecular fluorophore GFP 
to CP with efficient FRET capability, enabling sensitive and reliable identification of sixteen 
different cell types. Notably, isogenic healthy, cancerous, and metastatic cells that possess the 
same genetic background were readily discerned using only four CP-GFP dyads, requiring only 
2000 cells. The sensor array detect the overall molecular differences on the cell surfaces; 
importantly, its ability to differentiate between isogenic cells differing in glycosylation patterns 
opens up new opportunities for cancer diagnostics using glycan biomarkers. Given the 
ratiometric nature, these systems have the potential to study disease state-dependent biophysical 
changes on cell surfaces that would not depend on sampling. Furthermore, the availability of 
polymers in a variety of colors arising from backbone and side-chain modifications,
36
 and a 
range of fluorescent proteins,
37
 should enable fabrication of multichannel sensors, allowing one-
well detection
32,38
 of bioanalytes in a ratiometric and multiplexed format. Taken together, this 
first ever ratiometric sensor array for mammalian cell holds great promise for profiling benign 
and cancer cells, personalized screening of disease states, creating cellular imaging agents, and 
cell-based high-throughput screening of therapeutics. 
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